androsterone has been researched along with Diabetes Mellitus, Type 2 in 1 studies
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Another pandemic disease is type II diabetes mellitus (T2D) that is estimated to affect half a billion people in the world." | 5.62 | 16α-Bromoepiandrosterone as a new candidate for experimental diabetes-tuberculosis co-morbidity treatment. ( Baay-Guzman, G; Barrios-Payan, JA; Bini, E; Carranza, A; Chamberlin, W; Ge, Y; Hernández-Pando, R; López-Torres, MO; Marquina-Castillo, B; Mata-Espinosa, D; Ramos-Espinosa, O; Torre-Villalvazo, I; Torres, N; Tovar, A; Yepez, SH, 2021) |
| "Another pandemic disease is type II diabetes mellitus (T2D) that is estimated to affect half a billion people in the world." | 1.62 | 16α-Bromoepiandrosterone as a new candidate for experimental diabetes-tuberculosis co-morbidity treatment. ( Baay-Guzman, G; Barrios-Payan, JA; Bini, E; Carranza, A; Chamberlin, W; Ge, Y; Hernández-Pando, R; López-Torres, MO; Marquina-Castillo, B; Mata-Espinosa, D; Ramos-Espinosa, O; Torre-Villalvazo, I; Torres, N; Tovar, A; Yepez, SH, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| López-Torres, MO | 1 |
| Marquina-Castillo, B | 1 |
| Ramos-Espinosa, O | 1 |
| Mata-Espinosa, D | 1 |
| Barrios-Payan, JA | 1 |
| Baay-Guzman, G | 1 |
| Yepez, SH | 1 |
| Bini, E | 1 |
| Torre-Villalvazo, I | 1 |
| Torres, N | 1 |
| Tovar, A | 1 |
| Chamberlin, W | 1 |
| Ge, Y | 1 |
| Carranza, A | 1 |
| Hernández-Pando, R | 1 |
1 other study available for androsterone and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
16α-Bromoepiandrosterone as a new candidate for experimental diabetes-tuberculosis co-morbidity treatment.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Androsterone; Animals; Antitubercular Agents; Comorbidity; Co | 2021 |